RT @OncBrothers@twitter.com
Day 1 #GI23 Highlights #CommunityOncology
1. #NeoAGIS: Chemo vs CROSS
2. #Infinity: NeoAdj IO dMMR G/GEJ Ca
3. #SPOTLIGHT: CLDN18.2 (Importance of NGS)- New SoC
4. #INTEGRATEIIA: Rego in pretreated pts
@ASCO@twitter.com #OncEd #MedEd #Oncology @OncoAlert@twitter.com @HemOncFellows@twitter.com #gism
: https://twitter.com/OncBrothers/status/1616211370411970561